Banagan, Baby Girl .
HRN: 26-00-11 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/03/2024
AMPICILLIN 250MG (VIAL)
10/03/2024
10/10/2024
IV
160mg
Q12H
PSNB (Home Delivery)
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes